sars-cov-2

Documents about sars-cov-2

• A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years#245579ClinicalTrials.gov
• Ultrasensitive Isothermal Detection of SARS-CoV-2 Based on Self-Priming Hairpin-Utilized Amplification of the G-Rich Sequence#337788KOASAS: KAIST Open Access Self-Archiving System
• Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study#342233IRIS
• Incident diabetes within the first two years after SARS-CoV-2 infection: a population-based retrospective cohort study of the Agency for Health Protection of Milan, Italy.#351729NCBI PubMed Central
• Viral pathogens in urban rats: A one health systematic review of global surveillance evidence#353865Europe PMC
• Impfbereitschaft von Patient*innen mit entzündlich-rheumatischen Erkrankungen gegen SARS-CoV-2: Eine multizentrische Befragung zu Beginn der Impfkampagne in Deutschland#378171JLUpub
• Determinación de inmunoglobulinas totales tras la vacunación anti-SARS-CoV-2 en voluntarios sanos#406624RDA UNR Dataverse OAI Archive
• COVID-19 Risk and Immunity in Montreal North: A Population based Study [RISC-MTL, study data contributed to the CITF Databank]#411196Borealis Dataverse OAI Archive
• Factors associated with reduction in quality of life after SARS-CoV-2 infection#417616Dbt
• High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022.#446412NCBI PubMed Central
• General Practitioners’ Practice premises and Risk of Viral Cross-Transmission: A French Observational Multicenter Study#670146HAL (France)
• Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Huasteco from the Tantoyuca Area#752595PhilArchive
• Image 1_Early monocyte subset signatures predict outcomes in unvaccinated COVID-19 patients.jpg#818385Figshare
• Image 3_Early monocyte subset signatures predict outcomes in unvaccinated COVID-19 patients.jpeg#818386Figshare
• Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.#825693ClinicalTrials.gov
• Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19#826592ClinicalTrials.gov
• A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans#827136ClinicalTrials.gov
• Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational Study#829701ClinicalTrials.gov
• A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.#853215ClinicalTrials.gov
• CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools#876140ClinicalTrials.gov
• Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19#880903ClinicalTrials.gov
• A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)#10469OpenAlex
• Combat COVID-19 with artificial intelligence and big data#686560OpenAlex
• Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults#5148Europe PMC
• A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults#141109ClinicalTrials.gov
• Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults#154750ClinicalTrials.gov
• A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine#162554ClinicalTrials.gov
• A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine#181611ClinicalTrials.gov
• Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters#235407IRIS
• Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center#294808IRIS
• Multifunctional self-priming hairpin probe-based isothermal nucleic acid amplification and its applications for COVID-19 diagnosis#342280KOASAS: KAIST Open Access Self-Archiving System
• The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals#366651ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray#405191ClinicalTrials.gov
• hnRNPC facilitates coronavirus replication by directly binding the frameshift-stimulatory element of viral genomic RNA#437360PLOS
• No clear evidence of PFAS-induced immunomodulation in SARS-CoV-2-specific human T cell responses following vaccination#441182Springer Nature OA
• Targeting PTP4A3 and KVX-053 Mitigates Alcohol-Amplified SARS-CoV-2 Spike Protein-Induced Acute Lung Injury#483478ODU Digital Commons
• A combined PIE-FRET and FCS assay to monitor RNA dynamics and cleavage by SARS-CoV-2 Nsp15#485233Europe PMC
• High levels of cell-free hemoglobin and iron in cerebral thrombi of pre-Omicron COVID-19 stroke patients: novel drivers of SARS-CoV-2-induced prothrombotic state.#625903NCBI PubMed Central
• Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2#643633Harvard DASH
• Etablierung eines zellulären Interferon-gamma-basierten ELISpot assays in der ersten Phase der SARS-CoV-2- Pandemie 2020/2021 / Hanna Jury ; Gutachter: Martina Prelog, Manuel Krone#661673Deutsche Nationalbibliothek
• Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)#805249ClinicalTrials.gov
• Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.#812374ClinicalTrials.gov
• Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.#835355ClinicalTrials.gov
• Evaluation of Japan’s SARS-CoV-2 exit screening policy by analyzing airport screening data of travelers from the United Kingdom and Asia-Pacific#468526Kyoto University Research Information Repository
• Evaluation of Japan’s SARS-CoV-2 exit screening policy by analyzing airport screening data of travelers from the United Kingdom and Asia-Pacific#468554Kyoto University Research Information Repository
• Digital technology use during COVID ‐19 pandemic: A rapid review#653971OpenAlex
• Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers#828242ClinicalTrials.gov
• Unraveling the role of casein kinase 2 in the SARS-CoV-2 lifecycle : Implications for host-targeted antiviral development#124513HAL (France)
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China#6835OpenAlex
• On the footsteps of Hippocrates, Sanctorius and Harvey to better understand the influence of cold on the occurrence of COVID-19 in European countries in 2020#350795HAL (France)